MedTrace Logo

Locomotion and Global Positioning System in Arterial Disease

NCT00485147 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2012-07-02

No results posted yet for this study

Summary

The maximal walking distance (MWD) performed on treadmill (TT) remains the gold standard in estimating the walking capacity of patients suffering from peripheral arterial disease (PAD) with intermittent claudication, although treadmills are not accessible to most physicians. We hypothesized that global positioning system (GPS) recordings could monitor community-based outdoor walking and provide valid information on walking capacity in PAD patients.

Conditions

  • Peripheral Arterial Disease

Interventions

PROCEDURE

Recording of GPS during a free walking in a public park

Analyse the clinical change after surgery from GPS measurements and compare it with laboratory measurement.

Sponsors & Collaborators

  • Société Française de Médecine Vasculaire

    collaborator UNKNOWN

  • University Hospital, Angers

    lead OTHER_GOV

Principal Investigators

  • Pierre Abraham, MD, PhD · Laboratory for Vascular Investigations. University Hospital. Angers. France.

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00485147 on ClinicalTrials.gov